James Tobin, former CEO of Boston Scientific, has joined Aptus Endosystems' board of directors. The Sunnyvale, Calif.-based company develops systems for the treatment of abdominal aortic aneurysms.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||